New directions in hormone therapy for metastatic breast cancer.
Namer
M
M
Centre Antoine Lacassagne, Nice, France.
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D017024:Chemotherapy, Adjuvant; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D008408:Mastectomy / Q000379:methods; D009362:Neoplasm Metastasis; D016609:Neoplasms, Second Primary / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal